Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningxia Sikeda Biotechnology is a China-based manufacturer focused on pharmaceutical and pesticide intermediates rather than a therapeutic drug developer. The company was founded in 2014 and operates from Pingluo, Shizuishan, Ningxia, where it produces fine chemical intermediates including products such as 3-Isochromanone and 4-Chlorobenzaldehyde. Public business descriptions characterize it as a high-tech biopharmaceutical or biotech enterprise, but the available evidence points more specifically to commercial-scale manufacturing and sales of intermediates used in pharma and agrochemical supply chains. It appears to be an operating private company with meaningful industrial footprint, patents, and over 100 employees. No verifiable evidence was found of a clinical-stage therapeutic pipeline, named drug candidates, or disease-focused R&D programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningxia Sikeda Biotechnology.